Long-term outcomes and quality of life after intestine transplantation

Current Opinion in Organ Transplantation

Volumn 15, Issue 3, 2010, Pages 357-360

  Sudan, Debra ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Intestine transplant; Long term; Outcome; Quality of life; Survival

Indexed keywords

CANCER RISK; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CHILD NUTRITION; DIARRHEA; GOLD STANDARD; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; GROWTH RATE; HOSPITAL READMISSION; HUMAN; IMMUNOLOGICAL MONITORING; INTESTINE ABSORPTION; INTESTINE BIOPSY; INTESTINE TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ATTITUDE; QUALITY OF LIFE; RETRANSPLANTATION; REVIEW; SURVIVAL TIME; TREATMENT RESPONSE; VIRUS INFECTION;

CHILD; CHILD, PRESCHOOL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INTESTINAL DISEASES; INTESTINES; NUTRITIONAL STATUS; ORGAN TRANSPLANTATION; PARENTERAL NUTRITION; PATIENT READMISSION; PATIENT SELECTION; QUALITY OF LIFE; RECOVERY OF FUNCTION; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77953285419     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283398565     Document Type: Review

References (24)

1. Jeejeebhoy KN. Treatment of intestinal failure: transplantation or home parenteral nutrition? Gastroenterology 2008; 135:303-305.
2. Grant D, Abu-Elmagd K, Reyes J, et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg 2005; 241:607-613.
3. Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg 2009; 250:567-579.
4. Watson MJ, Venick RS, Kaldas F, et al. Renal function impacts outcomes after intestinal transplantation. Transplantation 2008; 86:117-122.
5. Fishbein TM. Intestinal transplantation. N Engl J Med 2009; 361:998-1008.
6. Sudan DL, Chinnakotla S, Horslen S, et al. Basiliximab decreases the incidence of acute rejection after intestinal transplantation. Transplant Proc 2002; 34:940-941.
7. Gupta A, Kumar CA, Ningappa M, et al. Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit antihuman thymocyte globulin. Transplantation 2009; 88:589-594.
8. + T cells identify rejection-prone recipients after pediatric small-bowel transplantation. Surgery 2009; 146:166-173.
9. David AI, Selvaggi G, Ruiz P, et al. Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation. Transplantation 2007; 84:1077-1081.
10. Sudan D, Vargas L, Sun Y, et al. Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. Ann Surg 2007; 246:311-315.
11. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006; 82:663-668.
12. + T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant 2009; 9:179-191.
13. Mazariegos GV, Soltys K, Bond G, et al. Pediatric intestinal retransplantation: techniques, management, and outcomes. Transplantation 2008; 86:1777-1782.
14. Lacaille F, Vass N, Sauvat F, et al. Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation. Gut 2008; 57:455-461.
15. Mazariegos GV, Squires RH, Sindhi RK. Current perspectives on pediatric intestinal transplantation. Curr Gastroenterol Rep 2009; 11:226-233.
16. Andersen DA, Horslen S. An analysis of the long-term complications of intestine transplant recipients. Prog Transplant 2004; 14:277-282.
17. Kato T, Selvaggi G, Gaynor JJ, et al. Inclusion of donor colon and ileocecal valve in intestinal transplantation. Transplantation 2008; 86:293-297.
18. Eisengart LJ, Chou PM, Iyer K, et al. Rotavirus infection in small bowel transplant: a histologic comparison with acute cellular rejection. Pediatr Dev Pathol 2009; 12:85-88.
19. Forstmeyer D, Henke-Gendo C, Brocker V, et al. Quantitative temporal and spatial distribution of adenovirus type 2 correlates with disease manifestations and organ failure during disseminated infection. J Med Virol 2008; 80:294-297.
20. Debray D, Baudouin V, Lacaille F, et al. De novo malignancy after solid organ transplantation in children. Transplant Proc 2009; 41:674-675.
21. Abu-Elmagd KM, Mazariegos G, Costa G, et al. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks. Transplantation 2009; 88:926-934.
22. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349:931-940.
23. Sudan D, Horslen S, Botha J, et al. Quality of life after pediatric intestinal transplantation: the perception of pediatric recipients and their parents. Am J Transplant 2004; 4:407-413.
24. Rovera GM, DiMartini A, Schoen RE, et al. Quality of life of patients after intestinal transplantation. Transplantation 1998; 66:1141-1145.